|
1
|
Wang J, Chen H, Zhang H, Yang F, Chen RP,
Li YB, Yang C, Lin SD, Chen LS, Liang GX and Cai DH: The
performance of a diabetic retinopathy risk score for screening for
diabetic retinopathy in Chinese overweight/obese patients with type
2 diabetes mellitus. Ann Med. 46:417–423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stryjewski TP, Papakostas TD and Vavvas D:
Proliferative hypertensive retinopathy. JAMA Ophthalmol.
134:345–346. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Erden S and Bicakci E: Hypertensive
retinopathy: Incidence, risk factors and comorbidities. Clin Exp
Hypertens. 34:397–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Del Brutto OH, Mera RM, Viteri EM, Pólit
J, Ledesma EA, Cano JA, Plaza KJ, Zambrano M and Costa AF:
Hypertensive retinopathy and cerebral small vessel disease in
amerindians living in rural ecuador: The atahualpa project. Int J
Cardiol. 218:65–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ong YT, Wong TY, Klein R, Klein BE,
Mitchell P, Sharrett AR, Couper DJ and Ikram MK: Hypertensive
retinopathy and risk of stroke. Hypertension. 62:706–711. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sairenchi T, Iso H, Yamagishi K, Irie F,
Okubo Y, Gunji J, Muto T and Ota H: Mild retinopathy is a risk
factor for cardiovascular mortality in Japanese with and without
hypertension: The Ibaraki prefectural health study. Circulation.
124:2502–2511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wong TY and Mcintosh R: Hypertensive
retinopathy signs as risk indicators of cardiovascular morbidity
and mortality. Br Med Bull. 73–74:57–70. 2005. View Article : Google Scholar
|
|
8
|
Kabedi NN, Kayembe DL, Mwanza JC, Lepira
FB and Kayembe TK: Hypertensive retinopathy and its association
with cardiovascular, renal and cerebrovascular morbidity in
Congolese patients. Cardiovasc J Afr. 25:228–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmieder RE: Hypertensive retinopathy: A
window to vascular remodeling in arterial hypertension.
Hypertension. 51:43–44. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grosso A, Veglio F, Porta M, Grignolo FM
and Wong TY: Hypertensive retinopathy revisited: Some answers, more
questions. Br J Ophthalmol. 89:1646–1654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li D, Lv J, Liu F, Liu P, Yang X, Feng Y,
Chen G and Hao M: Hypertension burden and control in mainland
China: Analysis of nationwide data 2003–2012. Int J Cardiol.
184:637–644. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J,
Wang X, Zhang H, Sun Y, Jia X, et al: Hypertension prevalence,
awareness, treatment and control in 115 rural and urban communities
involving 47 000 people from China. J Hypertens. 34:39–46. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang FH, Liang YB, Peng XY, Wang JJ, Zhang
F, Wei WB, Sun LP, Friedman DS, Wang NL and Wong TY: Handan Eye
Study Group: Risk factors for diabetic retinopathy in a rural
Chinese population with type 2 diabetes: The handan eye study. Acta
Ophthalmol. 89:e336–e343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
World Medical Association, . World Medical
Association Declaration of Helsinki. Ethical principles for medical
research involving human subjects. Bulletin of the World Health
Organization. 79:3732001.PubMed/NCBI
|
|
15
|
World Health Organization (WHO):
Guidelines on Basic Training and Safety in Acupuncture. WHO;
Geneva: 1999
|
|
16
|
Kapil V, Khambata RS, Robertson A,
Caulfield MJ and Ahluwalia A: Dietary nitrate provides sustained
blood pressure lowering in hypertensive patients: A randomized,
phase 2, double-blind, placebo-controlled study. Hypertension.
65:320–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Athikarisamy SE, Patole S, Lam GC, Dunstan
C and Rao S: Screening for retinopathy of prematurity (ROP) using
wide-angle digital retinal photography by non-ophthalmologists: A
systematic review. Br J Ophthalmol. 99:281–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Downie LE, Hodgson LA, Dsylva C, McIntosh
RL, Rogers SL, Connell P and Wong TY: Hypertensive retinopathy:
Comparing the keith-wagener-barker to a simplified classification.
J Hypertens. 31:960–965. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gholamhossein Y, Behrouz H and Asghar Z:
Diabetic retinopathy risk factors: Plasma erythropoietin as a risk
factor for proliferative diabetic retinopathy. Korean J Ophthalmol.
28:373–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Finzi A, Cellini M, Strobbe E and Campos
EC: ET-1 plasma levels, choroidal thickness and multifocal
electroretinogram in retinitis pigmentosa. Life Sci. 118:386–390.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bossard M, Pumpol K, van der Lely S,
Aeschbacher S, Schoen T, Krisai P, Lam T, Todd J, Estis J, Risch M,
et al: Plasma endothelin-1 and cardiovascular risk among young and
healthy adults. Atherosclerosis. 239:186–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Höglund K, Lequarré AS, Ljungvall I, Mc
Entee K, Merveille AC, Wiberg M, Gouni V, Willesen Lundgren J,
Hanås S, Wess G, et al: Effect of breed on plasma endothelin-1
concentration, plasma renin activity and serum cortisol
concentration in healthy dogs. J Vet Int Med. 30:566–573. 2016.
View Article : Google Scholar
|
|
23
|
Poulter NR, Prabhakaran D and Caulfield M:
Hypertension. Lancet. 386:801–812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mitchell GF: Arterial stiffness and
hypertension: Chicken or egg? Hypertension. 64:210–214. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeeb H, Hegewald J, Schubert M, Wagner M,
Dröge P, Swart E and Seidler A: Traffic noise and
hypertension-results from a large case-control study. Environ Res.
157:110–117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rizzoni D and Muiesan ML: Retinal vascular
caliber and the development of hypertension: A meta-analysis of
individual participant data. J Hypertens. 32:225–227. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Muraoka Y, Tsujikawa A, Kumagai K, Akiba
M, Ogino K, Murakami T, Akagi-Kurashige Y, Miyamoto K and Yoshimura
N: Age- and hypertension-dependent changes in retinal vessel
diameter and wall thickness: An optical coherence tomography study.
Am J Ophthalmol. 156:706–714. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li G, Shih YY, Kiel JW, De La Garza BH, Du
F and Duong TQ: MRI study of cerebral, retinal and choroidal blood
flow responses to acute hypertension. Exp Eye Res. 112:118–124.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Masaidi M, Cuspidi C, Giudici V, Negri F,
Sala C, Zanchetti A, Grassi G and Mancia G: Is retinal
arteriolar-venular ratio associated with cardiac and extracardiac
organ damage in essential hypertension? J Hypertens. 27:1277–1283.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmieder RE: Hypertensive retinopathy.
Ophthalmologica. 18:233–234. 2009.
|
|
31
|
Sarafidis PA and Bakris GL: Review:
Insulin and endothelin: An interplay contributing to hypertension
development? J Clin Endocrinol Metab. 92:379–385. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lankhorst S, Kappers MH, van Esch JH,
Danser AH and van den Meiracker AH: Mechanism of hypertension and
proteinuria during angiogenesis inhibition: Evolving role of
endothelin-1. J Hypertens. 31:444–454. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin Z, Luxiang C, Huadong Z, Zhiqiang X,
Lihua H and Huiyun L: C-338A polymorphism of the
endothelin-converting enzyme-1 gene and the susceptibility to
carotid atherosclerosis. Microvasc Res. 78:128–131. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
DeMing F: GW24-e1006 Effects of
telmisartan on left ventricular hypertrophy and expression of
endothelin-1 in spontaneously hypertensive rats. Heart. 99:A30–A31.
2013. View Article : Google Scholar
|
|
35
|
Heimlich JB, Speed JS, O'Connor PM,
Pollock JS, Townes TM, Meiler SE, Kutlar A and Pollock DM:
Endothelin-1 contributes to the progression of renal injury in
sickle cell disease via reactive oxygen species. Br J Pharmacol.
173:386–395. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Habib A, Alomari MA, Khaleghi M,
Morgenthaler NG, Struck J, Bergmann A, Mosley TH, Turner ST and
Kullo IJ: Plasma C-terminal pro-endothelin-1 is associated with
target-organ damage in African Americans with hypertension. Am J
Hypertens. 23:1204–1208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salvatore S and Vingolo EM: Endothelin-1
role in human eye: A review. J Ophthalmol. 2010:3546452010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Y, Hu S, Wu L, Fang X, Xu W and Shen
G: Clinical practice guidelines for hypertension in China: A
systematic review of the methodological quality. BMJ Open.
5:e0080992015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li X, Liu KL, Zheng JQ, Chi MG, Dong JJ,
Dong SJ and Gong ZH: Pharmacological characterization of
3-azabicyclo[3,2,1]
octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel
ET(A) receptor-selective ant. Pulm Pharmacol Ther. 21:780–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Prayitnaningsih S, Sujuti H, Hamid AA,
Permatasari N and Widodo MA: The effect of hypertension on
intraocular pressure and apoptosis of retinal ganglion cell through
ET-1 signaling pathway activation in trabecular meshwork of
hypertension rat model. Acta Ophthalmologica. 93:2015. View Article : Google Scholar
|
|
41
|
Tran HV, Emoto N, Vignon-Zellweger N,
Nakayama K, Yagi k, Suzuki Y and Hirata Ki: Analysis of ET-1 system
in mild and severe pulmonary arterial hypertension in mice. Life
Sciences. 93:e47. 2013. View Article : Google Scholar
|
|
42
|
Vizza CD, Letizia C, Badagliacca R, Poscia
R, Pezzuto B, Gambardella C, Nona A, Papa S, Marcon S, Mancone M,
et al: Relationship between baseline ET-1 plasma levels and outcome
in patients with idiopathic pulmonary hypertension treated with
bosentan. Int J Cardiol. 167:220–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gu X, Li H, Zhu X, Gu H, Chen J, Wang L,
Harding P and Xu W: Inverse correlation between plasma adropin and
ET-1 levels in essential hypertension: A cross-sectional study.
Medicine (Baltimore). 94:e17122015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oku H, Fukuhara M, Komori A, Okuno T,
Sugiyama T and Ikeda T: Endothelin-1 (ET-1) causes death of retinal
neurons through activation of nitric oxide synthase (NOS) and
production of superoxide anion. Exp Eye Res. 86:118–130. 2008.
View Article : Google Scholar : PubMed/NCBI
|
